06.06.2019 • News

Together for Sustainability: Bertrand Conquéret Elected as new President

The new TfS President, Bertrand Conquéret (Henkel), and the Steering...
The new TfS President, Bertrand Conquéret (Henkel), and the Steering Committeee members: (From left to the right in the back): Kristian Saksida (Solvay), Tom Witzel (BASF), Erk Thorsten Heyen (WACKER) (in the front): Gabriele Unger (TfS), Bertrand Conquéret (Henkel), Frederique van Baarle (LANXESS), Thomas Udesen (Bayer), Dirk Jan de With (Covestro). © Together for Sustainability

Bertrand Conquéret (Henkel) has been elected as new president of Together for Sustainability (TfS), taking over from Rüdiger Eberhard (Evonik), who led the initiative for the last 4 years.

In addition, the General Assembly of TfS elected Frederique van Baarle (Lanxess), Erk Thorsten Heyen (Wacker), Kristian Saksida (Solvay), Thomas Udesen (Bayer), Dirk Jan de With (Covestro), and Tom Witzel (BASF) as the new members of the Steering Committee.

“I am very pleased to have received the confidence of the TfS members to become president of our joined initiative and by that to be able to lead and shape TfS in the next two years!” said Conquéret. “All TfS members share the vision and responsibility for improving the sustainability performance of our suppliers. I am looking forward to bringing TfS closer to our shared goals – together with the 23 TfS members and the entire associated teams across companies and regions!"

Rüdiger Eberhard summarized: „As member of the TfS initiative, we all share the commitment to improve the sustainability performance of the suppliers in the chemical industry. I feel that the TfS leadership is in very good hands with Bertrand, who played a very active, committed and inspiring role in TfS from the very beginning.”

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

29 April 2026 | This webinar explores how chemical industry organizations can design a digital‑ and AI‑ready operating model focused on clarity, usability, and measurable value.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read